Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Sep;93(9):5246-5247.
doi: 10.1002/jmv.27084. Epub 2021 May 19.

Consider differentials before diagnosing SARS-CoV-2 associated Guillain-Barre syndrome

Josef Finsterer  1 , Fulvio A Scorza  2
Affiliations
Comment

Consider differentials before diagnosing SARS-CoV-2 associated Guillain-Barre syndrome

Josef Finsterer et al. J Med Virol. 2021 Sep.
No abstract available

PubMed Disclaimer

Conflict of interest statement

All the authors declare that there are no conflict of interests.

Comment on

Similar articles

See all similar articles

Cited by

References

    1. Manganotti P, Bellavita G, D'Acunto L, et al. Clinical neurophysiology and cerebrospinal liquor analysis to detect Guillain‐Barré syndrome and polyneuritis cranialis in COVID‐19 patients: a case series. J Med Virol. 2021;93:766‐774. 10.1002/jmv.26289 - DOI - PMC - PubMed
    1. Sriwastava S, Kataria S, Tandon M, et al. Guillain Barré Syndrome and its variants as a manifestation of COVID‐19: a systematic review of case reports and case series. J Neurol Sci. 2021;420:117263. 10.1016/j.jns.2020.117263 - DOI - PMC - PubMed
    1. Shahrizaila N, Lehmann HC, Kuwabara S. Guillain‐Barré syndrome. Lancet 2021;397:1214‐1228. 10.1016/S0140-6736(21)00517-1 - DOI - PubMed
    1. Zareifopoulos N, Lagadinou M, Karela A, Kyriakopoulou O, Velissaris D. Neuropsychiatric effects of antiviral drugs. Cureus 2020;12:e9536. 10.7759/cureus.9536 - DOI - PMC - PubMed
    1. Mortaz E, Bassir A, Dalil Roofchayee N, et al. Serum cytokine levels of COVID‐19 patients after 7 days of treatment with Favipiravir or Kaletra. Int Immunopharmacol. 2021;93:107407. 10.1016/j.intimp.2021.107407 - DOI - PMC - PubMed